The stock price of Regeneron has seen a 6% fall over the last twenty-one trading days, while it is down 7% over the last week. The volatility in REGN stock is being driven by the developments for REGEN-COV, its Covid-19 antibody cocktail. The therapy loses its efficacy against Omicron, which is...
The stock price of Regeneron has seen a 6% fall over the last twenty-one trading days, while it is down 7% over the last week. The volatility in REGN stock is being driven by the developments for REGEN-COV, its Covid-19 antibody cocktail. The therapy loses its efficacy against Omicron, which is...
Share this Article
Recommended